The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sing, 1985, Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation, Am J Hum Genet, 37, 268
Boerwinkle, 1988, Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B and cholesterol metabolism, Am J Hum Genet, 42, 104
Rall, 1982, Human apolipoprotein E: The complete amino acid sequence, J Biol Chem, 256, 4171, 10.1016/S0021-9258(18)34702-1
Rall, 1983, Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo- and hypercholesterolemic dysbetalipoproteinemia, J Clin Invest, 71, 1023, 10.1172/JCI110829
Robertson, 1985, Effects of apoprotein E polymorphism on serum lipoprotein concentration, Arteriosclerosis, 5, 283, 10.1161/01.ATV.5.3.283
Enholm, 1986, Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to protein concentrations, J Lipid Res, 27, 227, 10.1016/S0022-2275(20)38833-7
Assmann, 1984, Apolipoprotein E polymorphism and hyperlipidemia, Clin Chem, 30, 641, 10.1093/clinchem/30.5.641
Kobori, 1988, Influence of apolipoprotein levels, and clinical characteristics due to apolipoprotein E phenotype E22 in Japan, Atherosclerosis, 69, 81, 10.1016/0021-9150(88)90291-2
Tsuchiya, 1987, Association of the apolipoprotein E4 allele with hypercholesterolemia in apparently healthy male alleles in Tokyo, Jpn J Hum Genet, 32, 283, 10.1007/BF01910283
Utermann, 1984, Apolipoprotein E phenotypes and hyperlipidemia, Hum Genet, 65, 232, 10.1007/BF00286508
Weisgraber, 1984, A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1, J Clin Invest, 73, 1024, 10.1172/JCI111287
Havekes, 1984, Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinemic patient, Eur J Clin Invest, 14, 7, 10.1111/j.1365-2362.1984.tb00696.x
Goldstein, 1985, Familial hypercholesterolemia: A genetic receptor disease, Hosp Pract, 20, 35, 10.1080/21548331.1985.11703185
Eto, 1988, Familial hypercholesterolemia and apolipoproteinemia E4, Atherosclerosis, 72, 123, 10.1016/0021-9150(88)90072-X
Nestruck, 1987, Apolipoprotein E polymorphism and plasma cholesterol response to probucol, Metabolism, 36, 743, 10.1016/0026-0495(87)90110-7
Grundy, 1988, HMG-CoA reductase inhibitors for treatment of hypercholesterolemia, N Engl J Med, 319, 24, 10.1056/NEJM198807073190105
Tobert, 1988, Efficacy and long-term adverse effect pattern of lovastatin, Am J Cardiol, 62, 28J, 10.1016/0002-9149(88)90004-5
Illingworth, 1984, Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia, Ann Intern Med, 101, 598, 10.7326/0003-4819-101-5-598
Gibson, 1987, Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia, Arteriosclerosis, 7, 401, 10.1161/01.ATV.7.4.401
BioRad Laboratories, 1979
SAS Institute Inc, 1985
Davignon, 1988, Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis, 8, 1, 10.1161/01.ATV.8.1.1
Miida, 1988, Apolipoprotein E isoform phenotypes in familial hypercholesterolemia and coronary artery disease, 605
Kovanen, 1981, Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog, 78, 1194
Bilheimer, 1983, Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes, 80, 4124
Kesaniemi, 1988, Lovastatin and colestipol treatment and apolipoprotein E phenotype, 454
Berg, 1987, Genetics of coronary heart disease and its risk factors, 130, 14
Innerarity, 1987, Familial defective apolipoprotein B-100: Low density lipoproteins with abnormal receptor binding, 84, 6919